These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
340 related items for PubMed ID: 7010029
1. [anti-platelet therapy or anti-coagulants as prevention in transient ischemic attacks and reversible ischemic stroke]. Brechter C, Bäcklund H, Krook H, Müller R, Nitelius E, Olsson JE, Olsson O, Thornberg A. Lakartidningen; 1980 Dec 24; 77(52):4947-56. PubMed ID: 7010029 [No Abstract] [Full Text] [Related]
2. Antiplatelet therapy in ischemic stroke: variability in clinical trials and its impact on choosing the appropriate therapy. Biller J. J Neurol Sci; 2009 Sep 15; 284(1-2):1-9. PubMed ID: 19380153 [Abstract] [Full Text] [Related]
3. [Preventive drug therapy of transient cerebral ischemic attacks]. Sørensen PS, Marquardsen J. Ugeskr Laeger; 1982 Aug 09; 144(32):2357-60. PubMed ID: 7147462 [No Abstract] [Full Text] [Related]
4. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial. Serebruany VL, Malinin AI, Pokov AN, Hanley DF. Clin Ther; 2008 Feb 09; 30(2):249-59. PubMed ID: 18343263 [Abstract] [Full Text] [Related]
5. Use of dipyridamole in patients with recent stroke or TIA. Bernstein RA. Am Fam Physician; 2005 Aug 01; 72(3):382, 384; author reply 384. PubMed ID: 16100852 [No Abstract] [Full Text] [Related]
6. [Transient cerebral ischemic attacks. Treatment program and comparison between anticoagulants and thrombocyte aggregation repressors]. Burén A, Ygge J. Lakartidningen; 1979 Aug 22; 76(34):2784-7. PubMed ID: 529907 [No Abstract] [Full Text] [Related]
7. ESPRIT: is aspirin plus dipyridamole superior to aspirin alone in TIA or minor stroke patients? Rouhl RP, Lodder J. Expert Rev Neurother; 2008 Nov 22; 8(11):1661-5. PubMed ID: 18986236 [Abstract] [Full Text] [Related]
8. The European Stroke Prevention Study (ESPS): results by arterial distribution. Sivenius J, Riekkinen PJ, Smets P, Laakso M, Lowenthal A. Ann Neurol; 1991 Jun 22; 29(6):596-600. PubMed ID: 1892362 [Abstract] [Full Text] [Related]
9. Platelet inhibitors in the treatment of thrombosis. Hirsh J. Clin Invest Med; 1978 Jun 22; 1(3-4):191-206. PubMed ID: 391458 [No Abstract] [Full Text] [Related]
10. [Role of antiplatelet agents in the prevention of cerebral ischemic accidents]. Bousser MG. J Mal Vasc; 1983 Jun 22; 8(1):17-22. PubMed ID: 6341494 [Abstract] [Full Text] [Related]
17. Summary of ongoing clinical trials of platelet-active drugs in cardiovascular disease. Passamani ER. Circulation; 1980 Dec 15; 62(6 Pt 2):V106-10. PubMed ID: 7002348 [Abstract] [Full Text] [Related]
18. Secondary stroke prevention with antiplatelet drugs: have we reached the ceiling? Diener HC. Int J Stroke; 2006 Feb 15; 1(1):4-8. PubMed ID: 18706062 [Abstract] [Full Text] [Related]
19. Stroke therapy: status of anti-platelet aggregation drugs. Yatsu FM. Neurology; 1977 Jun 15; 27(6):503-4. PubMed ID: 325429 [No Abstract] [Full Text] [Related]